On May 9, 2024, Eledon Pharmaceuticals, Inc closed the transaction. The company has received $49,999,010 from 24 investors pursuant to exemption provided under Regulation D. The company has paid fees $1,617,174 to placements.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.73 USD | +3.80% | -9.90% | +51.67% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.67% | 105M | |
+15.19% | 121B | |
+19.91% | 114B | |
+8.24% | 23.61B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B |
- Stock Market
- Equities
- ELDN Stock
- News Eledon Pharmaceuticals, Inc.
- Eledon Pharmaceuticals, Inc. announced that it has received $49.99901 million in funding